Literature DB >> 35135135

Entrectinib in TRK and ROS1 Fusion-Positive Metastatic Pancreatic Cancer.

Michael J Pishvaian1, Ignacio Garrido-Laguna1, Stephen V Liu1, Pratik S Multani1, Edna Chow-Maneval1, Christian Rolfo1.   

Abstract

Entities:  

Year:  2018        PMID： 35135135     DOI： 10.1200/PO.18.00039

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  2 in total

Review 1.  Translational advances in pancreatic ductal adenocarcinoma therapy.

Authors:  Abdel Nasser Hosein; Stephanie K Dougan; Andrew J Aguirre; Anirban Maitra
Journal:  Nat Cancer       Date:  2022-03-29

2.  Case Report: Short-Term Response to First-Line Crizotinib Monotherapy in a Metastatic Lung Adenocarcinoma Patient Harboring a Novel TPR-ROS1 Fusion.

Authors:  Shuli Wei; Mangsha Hu; Yan Yang; Xiaojie Huang; Baizhou Li; Liren Ding; Pingli Wang
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.